Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
05 June 2025 | Story Vuyelwa Mbebe and Aimee Barlow | Photo Supplied
KovsieCricket
From left to right: Xander Snyders, President: Free State Cricket Union; Rocky le Roux, Head of KovsieCricket at the UFS; and Donavin George, Mangaung Cricket Association Chairperson.

The University of the Free State’s (UFS) KovsieCricket club was honoured with two of the most significant awards at the recent Mangaung Cricket Association Annual General Meeting (MCA AGM).

First, KovsieCricket was crowned MCA Premier League Champions, marking a remarkable twelfth consecutive title in the region’s top league. Later, the club was named the Best Run Cricket Club in the Free State, a recognition that goes beyond match victories.

The MCA AGM, which reflects on the regional cricketing year, this year included key updates from MCA Chairperson Donavin George, a review of the season’s performance, and the election of the executive committee for the new term. The AGM also celebrates excellence, dedication, and growth within the sport during the preceding year.

Rocky le Roux, Head of Cricket at the UFS, reflected on the evening’s achievements by attributing them to the unified effort of everyone involved in the club. “These accolades are the result of unwavering dedication from our players, coaches, management, and support staff,” he said. “Our student-athletes lay the foundation with their performances, but none of this would be possible without the people working tirelessly behind the scenes. Teamwork, long-term planning, and a shared vision have allowed us to achieve this consistency.”

The Best Run Cricket Club award serves as a powerful validation of the systems and values in place at KovsieCricket, Le Roux said, adding that awards of these types are not only a source of pride but are instrumental in attracting top talent from around the country. “They show young cricketers that KovsieCricket is a place where they can grow, compete, and thrive – not just on the field, but as professionals and leaders.”

With regional dominance firmly established, KovsieCricket’s sights are now set on national excellence. Le Roux believes that becoming the best cricket club in South Africa is a realistic goal, but one that will require strategic growth in several key areas. He emphasised the need for permanent, experienced coaches to guide development, an even stronger recruitment network, facilities that meet national standards, and a culture of belonging that inspires players to invest fully in the club. He also stressed that consistent exposure to higher levels of competition and a focus on mental resilience will be critical in the journey ahead.

As KovsieCricket celebrates these milestones, Le Roux extended heartfelt gratitude to those who make the journey possible. He acknowledged Jerry Laka, Director of KovsieSport at the UFS, the KovsieSport team for their unwavering support, the players and coaches for their commitment to excellence, and Francis Marais, Supervisor of the sports grounds and grounds staff, for consistently preparing top-quality pitches. He also thanked the Mangaung Cricket Association for their continued efforts in running competitive leagues and providing the resources that help the game thrive in the Free State.

With another successful season behind it, KovsieCricket looks to the future with confidence and ambition. Trophies alone do not define the legacy they are building – rather, their culture of excellence, community, and purpose sets the standard for university cricket in South Africa and beyond.

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept